Apr 11, 2013, 05.04 PM | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com advises to buy Aurobindo Pharma.
Sudarshan Sukhani (more)
Technical Analyst, s2analytics.com | Capital Expertise: Equity - Technical
"Aurobindo Pharma was in my buy list yesterday and today again afternoon when we were discussing stocks, I suggested again buying it. The stock charts are very nice. It is suggesting a significant up move is in the offing. It is not a day trade rather. It is really something one would want to hold on for a couple of days to get the real benefit.”
Aurobindo Pharma has inked a pact to acquire selec
Over the past few months, US FDA has given a go-ah
Ashwani Gujral of ashwanigujral.com is of the view